| Schedule of revenues and net income from operations |
| Schedule of revenues and net income
from operations | |
| | | |
| | |
| Asset: | |
March 31, 2024 | | |
December 31, 2023 | |
| Healthcare | |
$ | 20,227,446 | | |
$ | 18,955,991 | |
| Real Estate | |
| 586,582 | | |
| 587,456 | |
| Others | |
| 1,791,282 | | |
| 1,202,364 | |
| Consolidated assets | |
$ | 22,605,310 | | |
$ | 20,745,811 | |
| | |
Three Months Ended March 31, | |
| | |
2024
(Restated) | | |
2023 | |
| Revenues: | |
| | | |
| | |
| Healthcare | |
$ | 2,322,132 | | |
$ | 2,706,399 | |
| Real Estate | |
| – | | |
| – | |
| Consolidated revenues | |
$ | 2,322,132 | | |
$ | 2,706,399 | |
| | |
| | | |
| | |
| Cost of sales: | |
| | | |
| | |
| Healthcare | |
$ | 948,154 | | |
$ | 956,295 | |
| Real Estate | |
| – | | |
| – | |
| Consolidated cost of sales | |
$ | 948,154 | | |
$ | 956,295 | |
| | |
| | | |
| | |
| Income from operations from subsidiaries | |
| | | |
| | |
| Healthcare | |
$ | 1,151,284 | | |
$ | 1,278,239 | |
| Real Estate | |
| (874 | ) | |
| (97 | ) |
| Income from operations from subsidiaries | |
$ | 1,150,410 | | |
$ | 1,278,142 | |
| | |
| | | |
| | |
| Loss from operations from Cardiff Lexington | |
$ | (931,418 | ) | |
$ | (520,594 | ) |
| Total income from operations | |
$ | 218,992 | | |
$ | 757,548 | |
| | |
| | | |
| | |
| Income before taxes | |
| | | |
| | |
| Healthcare | |
$ | 1,151,284 | | |
$ | 817,098 | |
| Real Estate | |
| (874 | ) | |
| (97 | ) |
| Corporate, administration and other non-operating expenses | |
| (1,322,202 | ) | |
| (787,502 | ) |
| Consolidated income (loss) before taxes | |
$ | (171,792 | ) | |
$ | 29,499 | |
|